Key result
A convalescence strategy based on the assessment of autonomic nervous system activity using heart rate variability allowed a safe return to play and improved physical fitness without relapse.
Why the study?
Does a convalescence program guided by autonomic nervous system activity improve physical fitness and prevent relapse in an elite athlete recovering from infectious mononucleosis?
Case Report (n=1)
No
Does a convalescence program guided by autonomic nervous system activity improve physical fitness and prevent relapse in an elite athlete recovering from infectious mononucleosis?
A convalescence program guided by heart rate variability may facilitate safe return to play for athletes recovering from infectious mononucleosis.
May warrant HRV-guided monitoring for athlete return to play post-mononucleosis; leaves open confirmation in controlled trials.
Background: Infectious mononucleosis (IM) is an acute serious illness which requires among other things an interruption of training. The return to play for athletes after IM is complicated and a long-term process which could result in the relapse of health complications linked fundamentally with the illness. Objective: The aim of this study was to design a convalescence program which leads to an improvement in physical fitness and provides a safe return to play without relapse of health complications for an elite athlete who suffered from IM. Methods: The convalescence program lasted almost 3 months. Training load was optimized based on autonomic nervous system (ANS) activity which was assessed by spectral analysis (SA) of heart rate variability (HRV). There were evaluated an individual spectral variables: very low frequency power (PVLF) (0.02-0.05 Hz); low frequency power (PLF) (0.05-0.15 Hz), high frequency power (PHF) (0.15-0.50 Hz), total power (PT) (0.02-0.50 Hz), ratio PVLF/PHF and PLF/PHF; heart rate (HR), and age-dependent complex index of SA HRV: index of vagal activity, sympathovagal balance, and total score. Further, perceived exertion during exercise and morning fatigue was assessed. Repeated biochemical analysis was focused on the selected transaminase level. Results: Among recovery periods, an increase in mean of PT was accompanied by elevation of PVLF/PHF and PLF/PHF. No significant differences in mean values of any complex index of SA HRV among periods were found. A decline in HR was identified during measurements in lying, but mostly in supine. A significant elevation of perceived exertion during exercise occurred between periods. The morning fatigue culminated during the last period. No relationship between subjective feeling of fatigue and complex index of SA HRV was found. Conclusions: A convalescence strategy based on assessment of ANS activity brought an improvement in physical fitness, in spite of borderline or mild elevated transaminase level. We suggest that a combination of both non-invasive SA HRV and periodic assessment of biochemical indicators of liver state seems to be a promising strategy for determination of safe application of training load during convalescence after IM.
No takes yet. Share an insight, caveat, or question.
Botek et al. (2012) conducted a case report in Infectious mononucleosis (n=1). Convalescence program guided by autonomic nervous system activity (SA HRV) was evaluated on Autonomic nervous system activity (spectral variables of HRV) and physical fitness improvement without relapse. A convalescence strategy based on the assessment of autonomic nervous system activity using heart rate variability allowed a safe return to play and improved physical fitness without relapse.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: